Clinical Trials on Human Health

Total 94678 results

Regenstrief Institute, Inc.
Merck Sharp & Dohme LLC

Completed

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Cervical Cancer | Human Papilloma Virus Infection Type 11 | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18 | Human Papilloma Virus Infection Type 6

United States
St. Petersburg Research Institute of Vaccines and...

Completed

Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

Influenza | Flu, Human

Russian Federation
Brigham and Women's Hospital
Department of Health and Human Services; Centers for Medicare and Medicaid... and other collaborators

Completed

Mail Outreach To Increase Vaccination Acceptance Through Engagement (MOTIVATE)

Influenza | Influenza, Human | Human Flu

United States
Novartis
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.

Human Influenza

Brazil
Butantan Institute
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients

Human Influenza

Brazil
Centers for Disease Control and Prevention
Universidad del Valle, Guatemala; Hospital Nacional San Juan de Dios de Santa... and other collaborators

Terminated

Panama and El Salvador Children's Oseltamivir Study (PECOS)

Influenza | Human Influenza

Panama, El Salvador
Novartis Vaccines

Completed

Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects

Human Influenza

Belgium
Hualan Biological Engineering, Inc.

Completed

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

Human Influenza

China
Meso Scale Diagnostics, LLC.
Centers for Disease Control and Prevention

Terminated

Clinical Validation of the Point-of-Care MSD Influenza Test

Influenza Human

United States
Chinese Academy of Sciences
Jiangsu Province Centers for Disease Control and Prevention; Hualan Biological...

Unknown

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Human Influenza

China
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Active, not recruiting

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA (HESTIA)

Human Papillomavirus-Related Carcinoma | Human Papillomavirus Positive Oropharyngeal Carcinoma | Human Papillomavirus Positive Cervical Carcinoma | Human Papillomavirus Positive Anal Carcinoma | Human Papillomavirus Positive Vulvar Carcinoma | Human Papillomavirus Positive Penile Carcinoma

United States
Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
Novartis Vaccines

Completed

Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above

Human Influenza

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age

Human Influenza

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above

Human Influenza

Germany
Hualan Biological Engineering, Inc.

Completed

Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine

Human Influenza

China
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Influenza (Healthy Volunteers)

Germany, Finland
LG Life Sciences

Completed

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Healthy Infants

Korea, Republic of
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Active, not recruiting

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Human Immunodeficiency Virus I Infection | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Influenza (Healthy Volunteers)

Germany, Finland
Sanofi Pasteur, a Sanofi Company

Completed

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

Influenza (Healthy Volunteers)

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Taiwan
Institut de Recherche en Sciences de la Sante,...
Bill and Melinda Gates Foundation; University Ghent

Recruiting

Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women (LAFIABAGA)

Inflammation | Microbiome, Human

Burkina Faso
University of California, San Diego

Terminated

Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation (TRIPH2017)

Human Microbiome

United States
University of Erlangen-Nürnberg Medical School

Completed

Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation

Human Microbiome

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Human Papillomavirus (HPV) Infection

Senegal, Tanzania
Vaccitech (UK) Limited
University of Oxford

Completed

A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Human Volunteers

United Kingdom
Centre Hospitalier de Cayenne

Completed

Epidemiology of Human Papillomavirus Infection Among Women Living on the Maroni and the Oyapock Rivers (EPHaVI)

Human Papillomavirus Viruses
University of Utah
Bayer

Completed

Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement

Contraception | Cytokine | Metagenome | Human Microbiome

United States
Walter Reed Army Medical Center
Eastern Virginia Medical School; University of Virginia; James Madison University

Completed

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

Tear Protein Lacritin in Human Tears

United States
San Diego State University

Active, not recruiting

Impacts of Fruit on the Gut Health and Human Health

Healthy Aging | Cognition | Cardiometabolic Health

United States
Merck Sharp & Dohme LLC

Completed

GARDASIL Reexamination Study (V501-059)

Human Papillomavirus (HPV) Infection
University of Calgary
Canadian Institutes of Health Research (CIHR); British Columbia Farmers' Market...

Completed

Impact of BC Farmers' Market Nutrition Coupon Program on Diet Quality and Psychosocial Well-being of Low-income Adults

Diet, Healthy | Health Risk Behaviors

Canada
New York University
American Composers Orchestra

Recruiting

A Music and Visual Arts Digital Intervention in Teenagers to Promote Healthy Engagement With Social Media. (SMART)

Healthy Subjects | Mental Health Issue

United States
Fundació Eurecat
Centre de Recerca en Economia i Desenvolupament Agroalimentari-UPC-IRTA (CREDA) and other collaborators

Enrolling by invitation

Switching Mediterranean Consumers to Mediterranean Sustainable Healthy Dietary Patterns

Healthy Subjects | Family | Behavior, Health

Spain
Taipei Medical University WanFang Hospital
Taipei Medical University

Completed

The Factors Affecting Intentions of Medical Staff to Use Personal Health Record in Northern Hospitals of Taiwan

Healthy Subjects | Health Care Providers

Taiwan
Seqirus

Completed

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

Virus Diseases | Influenza | Human

United States
University of Athens
Hellenic Pasteur Institute

Completed

Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020

Influenza in Human

Greece
Pantec Biosolutions AG
Medical University of Vienna

Completed

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Influenza in Human

Austria
Assistance Publique - Hôpitaux de Paris

Completed

Face Masks for Preventing Influenza Transmission (GRIPMASK)

Influenza Human

France
Jacobs University Bremen gGmbH

Recruiting

Planetary Health and Loneliness (PAL)

Anxiety | Health Behavior | Loneliness | Healthy Diet | Health-Related Behavior | Healthy Lifestyle | Healthy Nutrition

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Healthy Volunteers | Influenza Immunization

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

Healthy Volunteers | Influenza Immunization

Japan
University of Oxford

Completed

Observational Study of Immune Response to Hepatitis B Childhood Booster

Healthy

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Healthy Volunteers | Influenza Immunization

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Healthy Volunteers | Influenza Immunization

France, Belgium, Germany, Italy, Netherlands, Poland
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

Healthy Volunteers | Influenza Immunization

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects (FBP00004)

Healthy Volunteers | Influenza Immunisation

United States
Vaccitech (UK) Limited

Completed

First in Human Study of ChAdOx1-HBV

Healthy | Hepatitis B

United Kingdom

Clinical Trials on Human Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations